Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) is expected to be announcing its results before the market opens on Thursday, November 5th. Analysts expect the company to announce earnings of $0.3778 per share and revenue of $7.64 billion for the quarter.
Siemens Healthineers Price Performance
OTCMKTS:SMMNY opened at $23.74 on Thursday. Siemens Healthineers has a 12-month low of $19.20 and a 12-month high of $28.73. The stock’s 50 day simple moving average is $22.40 and its 200-day simple moving average is $22.04.
Analysts Set New Price Targets
A number of research firms recently weighed in on SMMNY. Zacks Research lowered shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 1st. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Siemens Healthineers in a research note on Tuesday, August 18th. Royal Bank Of Canada restated an “outperform” rating on shares of Siemens Healthineers in a research report on Friday, October 16th. Finally, Citigroup restated a “buy” rating on shares of Siemens Healthineers in a research note on Tuesday, October 13th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Siemens Healthineers has a consensus rating of “Moderate Buy”.
View Our Latest Stock Analysis on Siemens Healthineers
About Siemens Healthineers
Siemens Healthineers AG is a global medical technology company headquartered in Erlangen, Germany. The company develops, manufactures and provides products, services and digital solutions that support the prevention, diagnosis and treatment of disease. Siemens Healthineers operates as a separately managed company within the broader Siemens group and has served healthcare providers in markets around the world.
Its portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, X-ray and molecular imaging equipment, as well as ultrasound systems.
Further Reading
- Five stocks we like better than Siemens Healthineers
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
